胸腔镜与开胸手术治疗肺癌的对比研究

目的:探讨胸腔镜下肺癌根治术的安全性及可行性。方法:对比2013年1月至2015年6月，36例胸腔镜下与50例开胸肺癌根治术的手术时间、术中失血量、术后下地时间、术后镇痛时间、术后引流时间、住院天数、术后并发症、医疗费用。结果:二种方法术后并发症无差异（P＞0.05）。胸腔镜组术中失血、术后下地、术后镇痛、术后引流、手术时间、住院天除医疗费用外均优于开胸组（P＜0.05），术前及术后第1天CRP、IL-6无差异（P＞0.05），术后第7天，胸腔镜组CRP与IL-6下降更快，优于开胸组（P＜0.05）。结论:胸腔镜治疗肺癌比开胸手术创伤小、愈合快、住院时间短。

Effect of VATS in thoracotomy for resectable lung cancer

Objective:To investigate the safety and efficacy of VATS for resectable non - small cell lung cancer (NSCLC). Methods:The clinical findings of 86 patients with NSCLC including 36 cases underwent VATS and 50 ca-ses underwent thoracotomy were retrospectively analyzed. Results:There was no significant difference between 2 groups in postoperative complications(P > 0. 05). But the blood loss during operation,postoperative lower,analgesic time,drainage duration and hospitalization except of medical expenses in VATS group were significantly less than that of thoracotomy group(P < 0. 05). The levels of the CRP and IL - 6 in the two groups were similar preoperatively and on the 1st day postoperatively(P > 0. 05). After operation one week the levels of the CRP and IL - 6 in VATS group was lower than that of the thoracotomy group( P < 0. 05). Conclusion:VATS is safe and minimally invasive for NSCLC surgery.